Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 122, Issue 2, Pages 122-123Publisher
WILEY
DOI: 10.1002/jso.26057
Keywords
chemotherapy; COVID-19; ovarian cancer; SARS-CoV; surgery
Ask authors/readers for more resources
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available